However, too many free radicals can overwhelm antioxidants, causing to oxidative stress and damaging cells
Future research should consider multi-modality treatment implications, including surgery and radiotherapy
Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO
These medications are gaining traction globally, driven by the rising prevalence of diabetes and obesity, indicating a strong demand for more accessible treatment options
The term GLP-1 agonist wriggled its way into our vocabulary with the discovery that weekly injections of semaglutide, the active ingredient in Ozempic and Wegovy, can cause significant weight loss